We are live on ! Find out more
PCRX icon

Pacira BioSciences
PCRX

276 hedge funds and large institutions have $3.04B invested in Pacira BioSciences in 2021 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 105 increasing their positions, 82 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

77% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 26

33% more funds holding in top 10

Funds holding in top 10: 3 → 4 (+1)

28% more repeat investments, than reductions

Existing positions increased: 105 | Existing positions reduced: 82

11% more capital invested

Capital invested by funds: $2.75B → $3.04B (+$298M)

7% more funds holding

Funds holding: 259 → 276 (+17)

3.11% more ownership

Funds ownership: 110.52% → 113.63% (+3.1%)

67% less call options, than puts

Call options by funds: $1.67M | Put options by funds: $5.08M

Holders
276
Holders Change
+17
Holders Change %
+6.56%
% of All Funds
4.25%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
46
Increased
105
Reduced
82
Closed
26
Calls
$1.67M
Puts
$5.08M
Net Calls
-$3.42M
Net Calls Change
-$7.42M

Top Buyers

Rank Fund Capital Flow
1
PC
Paulson & Co
New York
+$24.6M
2
AC
Armistice Capital
New York
+$20.7M
3
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
+$14.7M
4
Marshall Wace
Marshall Wace
United Kingdom
+$10.5M
5
HCM
Hodges Capital Management
Texas
+$9.26M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$20.5M
2
Wells Fargo
Wells Fargo
California
-$18M
3
NPIC
Neumeier Poma Investment Counsel
California
-$16.2M
4
Goldman Sachs
Goldman Sachs
New York
-$14.3M
5
TA
Tamarack Advisers
California
-$7.44M
Name Holding Trade Value Shares
Change 		Change in
Stake
First Eagle Investment Management
126
First Eagle Investment Management
New York
$1.49M +$1.37M +24,832 New
OF
127
Outfitter Financial
Maine
$1.49M +$55.1K +1,000 +4%
GAM
128
Gotham Asset Management
New York
$1.48M +$231K +4,198 +21%
UBS Group
129
UBS Group
Switzerland
$1.42M -$84.5K -1,533 -6%
FNBOO
130
First National Bank of Omaha
Nebraska
$1.41M +$22.8K +414 +2%
AB
131
Amalgamated Bank
New York
$1.38M -$15.8K -287 -1%
LSERS
132
Louisiana State Employees Retirement System
Louisiana
$1.3M +$11K +200 +0.9%
Royal Bank of Canada
133
Royal Bank of Canada
Ontario, Canada
$1.28M +$189K +3,436 +19%
State of Tennessee, Department of Treasury
134
State of Tennessee, Department of Treasury
Tennessee
$1.25M +$228K +4,131 +25%
Fisher Asset Management
135
Fisher Asset Management
Washington
$1.25M -$3.75K -68 -0.3%
Jane Street
136
Jane Street
New York
$1.23M +$629K +11,416 +127%
OAM
137
Oppenheimer Asset Management
New York
$1.21M -$68.2K -1,237 -6%
GIM
138
Goelzer Investment Management
Indiana
$1.2M -$40.1K -728 -4%
Ensign Peak Advisors
139
Ensign Peak Advisors
Utah
$1.11M -$506K -9,170 -33%
MSRPS
140
Maryland State Retirement & Pension System
Maryland
$1.07M +$13.7K +248 +1%
State Board of Administration of Florida Retirement System
141
State Board of Administration of Florida Retirement System
Florida
$1.05M -$36.9K -669 -4%
ProShare Advisors
142
ProShare Advisors
Maryland
$1.04M +$59.5K +1,079 +7%
OPERF
143
Oregon Public Employees Retirement Fund
Oregon
$1.02M -$44.1K -800 -5%
Osaic Holdings
144
Osaic Holdings
Arizona
$993K +$562K +10,191 +162%
US Bancorp
145
US Bancorp
Minnesota
$977K +$39.7K +720 +5%
AIA
146
Affinity Investment Advisors
California
$941K +$4.25K +77 +0.5%
MIM
147
MetLife Investment Management
New Jersey
$917K – – –
EAM
148
Erste Asset Management
Austria
$896K – – –
First Trust Advisors
149
First Trust Advisors
Illinois
$847K +$471K +8,551 +155%
TRCT
150
Tower Research Capital (TRC)
New York
$822K +$708K +12,843 +1,561%
4 5
6
7 8

PCRX Hedge Fund Activity: Q4 2021 in Review

276 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Pacira BioSciences (PCRX) for Q4 2021, worth a combined $3.04B — up 11% from $2.75B a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new PCRX positions and 26 closed out — a net gain of 20 holders — while 105 added to existing stakes and 82 trimmed.

The largest buyer was Paulson & Co, adding an estimated $24.6M. The largest seller was Deerfield Management, cutting an estimated $20.5M.

  • 276 institutional investors held Pacira BioSciences (PCRX) as of Q4 2021, up from 259 in Q3 2021.
  • Funds reported $3.04B of Pacira BioSciences stock for Q4 2021, up 11% quarter-over-quarter.
  • 46 funds opened new Pacira BioSciences positions in Q4 2021 and 26 closed out, a net change of +20 holders.
  • The largest Pacira BioSciences buyer in Q4 2021 was Paulson & Co, an estimated $24.6M added.
  • The largest Pacira BioSciences seller in Q4 2021 was Deerfield Management, an estimated $20.5M sold.

Based on aggregated 13F filings for Q4 2021.